Period7 Jun 2022 → 8 Jun 2022

Media coverage

2

Media coverage

  • TitlePositive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut Allergic Toddlers
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date8/06/22
    PersonsKurt Hirschhorn, Hugh Sampson
  • TitleDBV Technologies Announces Positive Topline Results From Phase 3 EPITOPE Trial Of Viaskin Peanut In Peanutallergic Toddlers
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date7/06/22
    PersonsKurt Hirschhorn, Hugh Sampson